William Loging
Impact in
-
- Computational Drug Discovery Methods
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Microbial Natural Products and Biosynthesis
Papers in
-
- Bioinformatics and Genomic Networks 5
- Receptor Mechanisms and Signaling 4
- Metabolomics and Mass Spectrometry Studies 3
- RNA modifications and cancer 3
- Oncology 8
- Cancer-related Molecular Pathways 4
- Co-authors
- Anton Fliri (7 shared papers)Robert A. Volkmann (7 shared papers)Peter F. Thadeio (3 shared papers)David Reisman (3 shared papers)Bryn Williams–Jones (1 shared paper)Lee Harland (2 shared papers)David Reisman (1 shared paper)Delvin R. Knight (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Journal of Medicinal Chemistry (2 papers)Nature Reviews Drug Discovery (2 papers)Clinical Cancer Research (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesIsraelUnited Kingdom
In The Last Decade
William Loging
21 papers receiving 969 citations
Peers
Comparison fields: 5 of 91
- Computational Theory and Mathematics 362
- Pharmacology 100
- Molecular Biology 547
- Cancer Research 93
- Oncology 162
Countries citing papers authored by William Loging
This map shows the geographic impact of William Loging's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Loging with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Loging more than expected).
Fields of papers citing papers by William Loging
This network shows the impact of papers produced by William Loging. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Loging. The network helps show where William Loging may publish in the future.
Co-authors
The 25 scholars most cited alongside William Loging, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 140 | |
| 2 | 2005 | 123 | |
| 3 | 2009 | 104 | |
| 4 | 2018 | 100 | |
| 5 | 2000 | 83 | |
| 6 | 2007 | 65 | |
| 7 | 2005 | 63 | |
| 8 | 1998 | 57 | |
| 9 | Elevated expression of ribosomal protein genes L37, RPP-1, and S2 in the presence of mutant p53. | 1999 | 54 |
| 10 | 1999 | 37 | |
| 11 | 2011 | 34 | |
| 12 | 2010 | 28 | |
| 13 | 2009 | 26 | |
| 14 | 2007 | 21 | |
| 15 | 2009 | 21 | |
| 16 | 1996 | 20 | |
| 17 | 2013 | 11 | |
| 18 | 2017 | 9 | |
| 19 | 2016 | 4 | |
| 20 | Analysis of information flows in interaction networks: implication for drug discovery and pharmacological research. | 2011 | 3 |
About William Loging
William Loging is a scholar working on Molecular Biology, Oncology, Computational Theory and Mathematics, Pharmacology and Immunology, having authored 22 papers that have together received 1.0k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (8 papers), Bioinformatics and Genomic Networks (5 papers), Cancer-related Molecular Pathways (4 papers), Receptor Mechanisms and Signaling (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Immunotherapy and Immune Responses (3 papers), Metabolomics and Mass Spectrometry Studies (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Computational Theory and Mathematics (362 citations), Pharmacology (100 citations), Molecular Biology (547 citations), Cancer Research (93 citations) and Oncology (162 citations). William Loging has collaborated with scholars based in United States, Israel and United Kingdom. Frequent co-authors include Anton Fliri, Robert A. Volkmann, Peter F. Thadeio, David Reisman, Bryn Williams–Jones, Lee Harland, David Reisman, Delvin R. Knight, Joan A. Keiser and David A. Perry. Their work appears in journals such as Journal of Clinical Oncology, Journal of Medicinal Chemistry, Nature Reviews Drug Discovery, Clinical Cancer Research and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.